AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05207358 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mycophenolate Mofetil
Description: Patients will receive Mycophenolate Mofetil, initially 500 mg twice daily, titrated to a maximum of 1.5 g twice daily, depending on leukocyte count and digestive tolerance, which will be maintained 24 months.
Study NCT05207358 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Cyclophosphamide
Description: All patients will receive Cyclophosphamide intravenously starting day 1, 6 pulses at a fixed dose of 500 mg given at 2 weeks. After 3 months, Azathioprine (2 mg / kg / day) is initiated 2 weeks after the last administration of Cyclophosphamide and maintained for the next 21 months.
Study NCT05207358 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Corticosteroids
Description: 3 daily pulses of 750 mg of intravenous Methylprednisolone, followed by oral corticosteroid therapy starting with a dose of 0.5 mg / kg / day for 4 weeks, then decreased by 2.5 mg of Prednisolone / day each 2 weeks. A low dose of glucocorticoid (5-7.5 mg / day) is maintained until 24 months after enrollment.
Study NCT05775705 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: L-DEP and PD-1 antibody
Description: Doxorubicin (doxorubicin hydrochloride liposome injection) 35 mg/m2 day 1; etoposide 75 mg/m2 day1; methylprednisolone 1.5mg/kg days 1 to 3, 0.25mg/kg day 4 to 14; PEG-aspargase 6000iu/m2 day2, day4; PD-1 antibody injection 200mg day 5.
Study NCT04966429 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Maraviroc
Description: Tablets
Study NCT04966429 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Maraviroc
Description: Tablets
Study NCT06373510 — intervention group
Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: Blood collection
Description: Collection of blood before and after a non mandatory vaccination
Study NCT04857710 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Wide-pulse neuromuscular electrostimulation (WP NMES)
Description: The WP NMES program consists of electrical stimulation trains of 1000 symmetrical biphasic pulses (1 ms, 100 Hz). The duration of a train is of 10 s and the rest between trains is of 30 s. A WP NMES session includes 30 evoked contractions. The stimulation intensity is monitored online and adjusted to the highest tolerable by the subjects.During the stimulation, subjects are seated with the knee joint fixed a 60° angle. Three self-adhesive electrodes are placed over the right thigh. The positive electrodes, measuring 25 cm² (5 x 5 cm), are placed as close as possible to the motor point of the vastus lateralis and vastus medialis muscles. The negative electrode, measuring 50 cm² (10 x 5 cm), is placed 5-7 cm below the inguinal ligament. Electrical stimulations are delivered by a stimulator BioStim (Mazet Santé).
Study NCT04857710 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Conventional neuromuscular electrostimulation (CONV NMES)
Description: The CONV NMES program consists of electrical stimulation trains of 500 symmetrical biphasic pulses (0.2 ms, 50 Hz). The duration of a train is of 10 s and the rest between trains is of 30 s (duty cycle: 1/3). A WP NMES session includes 30 evoked contractions. The stimulation intensity is monitored online and adjusted to the highest tolerable by the subjects.~During the stimulation, subjects are seated with the knee joint fixed a 60° angle. Three self-adhesive electrodes are placed over the right thigh. The positive electrodes, measuring 25 cm² (5 x 5 cm), are placed as close as possible to the motor point of the vastus lateralis and vastus medialis muscles. The negative electrode, measuring 50 cm² (10 x 5 cm), is placed 5-7 cm below the inguinal ligament. Electrical stimulations are delivered by a stimulator BioStim (Mazet Santé).
Study NCT04857710 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Control (CONT) modality
Description: Control (CONT) modality is used as a reference and is representative of a sedentary behaviour regularly observed in our populations.
Study NCT05607043 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Testing for SARS CoV2 RNA
Description: Device: Testing for SARS CoV2 RNA- lab-based RNA RT-PCR testing
Study NCT05134844 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hydrotherapy- Snoezelen
Description: Multi sensory approach in water
Study NCT05134844 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Snoezelen
Description: Multu Sensory approach on land
Study NCT05909423 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Influenza vaccine
Description: Intratumoral influenza vaccine treatment, administered via endoscopic procedure
Study NCT05909423 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Single dose pembrolizumab treatment
Study NCT05559541 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AK119
Description: AK119 is an anti-CD73 monoclonal antibody.
Study NCT05559541 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AK104
Description: AK104 is an anti-PD-1 and CTLA-4 bispecific antibody.
Study NCT04796896 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: mRNA-1273
Description: Sterile liquid for injection
Study NCT04796896 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: mRNA-1273
Description: Sterile liquid for injection
Study NCT04796896 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 0.9% sodium chloride (normal saline) injection
Study NCT04796896 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: mRNA-1273.214
Description: Sterile liquid for injection
Study NCT04796896 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: mRNA-1273.214
Description: Sterile liquid for injection
Study NCT05439564 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexmedetomidine
Description: Group morphine-Dex (35 patients): patients will be received given 0.5% heavy bupivacaine (3.5 ml) plus 0.1 mg of morphine plus 5 mcg of dexmedetomidine.
Study NCT05439564 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Morphine
Description: Group morphine (35 patients): patients will be received given 0.5% heavy bupivacaine (3.5 ml) plus 0.1 mg of morphine.
Study NCT05439564 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Morphine
Description: Group morphine (35 patients): patients will be received given 0.5% heavy bupivacaine (3.5 ml) plus 0.1 mg of morphine.
Study NCT05439564 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexmedetomidine
Description: Group Dex (35 patients): patients will be received given 0.5% heavy bupivacaine (3.5 ml) plus 5 mcg of dexmedetomidine.
Study NCT05249751 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Assessement of serum copeptin by ELISA technique
Description: Assessement of serum copeptin by ELISA technique
Study NCT05549245 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: high-flow nasal cannula oxygen therapy,
Description: Patients were treated with high-flow nasal cannula oxygen therapy for three nights
Study NCT05549245 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: CPAP
Description: Patients were treated with CPAP for three nights
Study NCT05261776 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: pilates exercise
Description: Pilates exercise for 40 minutes (5 minutes for warm-up and 30 minutes of pilates and 5 minutes for cool down). These participants will continue their standard care.~Patients in Group-A will get 40 minutes of session, Alternative three days/ week for 12 weeks.
Study NCT05261776 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: brisk walk
Description: Brisk walk on treadmill for 40 minutes (5 minutes for warm-up and 30 minutes of brisk walk on treadmill and 5 minutes for cool down). These participants will continue their standard care.~Patients in Group-B of 40 minutes of session, Alternative three days/ week for 12 weeks.
Study NCT04361175 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Letrozole
Description: Each group will be followed up for ovulation by day 12 ovulation monitoring by Transvaginal ultrasound for mature griffian follicle and measure endometrial thickness and volume then day 21 test serum progesterone level to confirm ovulation and if pregnancy occurred confirm by serum pregnancy test at day 35 of the cycle and follow pregnancy till confirmed by fetal pulsation by ultrasound.
Study NCT04361175 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clomiphine Citrate
Description: Clomiphine Citrate
Study NCT05508802 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: State Counselor-Coordinated Services
Description: A counselor affiliated with the New Jersey State Division of Vocational Rehabilitation Services coordinates services that consider the participant's condition, needs and goals. Services they may receive include:~* Education on programs designed to help people with spinal cord injury or brain injury pursue employment.~* Advice and guidance from professional counselors who have special training in helping people with disabilities pursue employment.~* Help completing applications for services.~* Assistance communicating with my employer about my needs and ways to accommodate them.~* Referrals to and services from other health care or technology providers.
Study NCT05508802 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Center Facilitator-Coordinated Services
Description: A facilitator affiliated with Kessler Institute for Rehabilitation coordinates services that consider the participant's condition, needs and goals. Services they may receive include:~* Education on programs designed to help people with spinal cord injury or brain injury pursue employment.~* Advice and guidance from professional counselors who have special training in helping people with disabilities pursue employment.~* Help completing applications for services.~* Assistance communicating with my employer about my needs and ways to accommodate them.~* Referrals to and services from other health care or technology providers.
Study NCT03459651 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ANS training
Description: In-home computer-based ANS training
Study NCT05524129 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: rehabilitation exercise
Description: Conventional rehabilitation exercise.
Study NCT05524129 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: rehabilitation exercise
Description: Conventional rehabilitation exercise.
Study NCT05524129 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: electrotherapy
Description: A middle frequency electro-therapy
Study NCT05516069 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Our Healthbox (smart vending machine or interactive dispensing system)
Description: Our Healthboxes or interactive dispensing systems (IDS) will be placed in various locations across Canada and will house HIV self-test kits (provided by REACH), harm reduction supplies (provided by the provincial governments / local community based organizations; e.g. sterile drug use kits for safer injection, naloxone kits, syringes), other community determined needs (including but not limited to hats, mittens and/or socks, rapid Covid-19 antigen kits, KN95 masks). Individuals will be able to access the HIV self-test kits and harm reduction and other materials directly from the machine. Our Healthbox will also provide health information, and a support services directory for people to find the health care they need - in their community.
Study NCT03936127 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Ultrasound (US) Targeted Fusion Biopsy
Description: Ultrasound (US) Targeted Fusion Biopsy
Study NCT03936127 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Ultrasound (US) Targeted Fusion Biopsy
Description: Ultrasound (US) Targeted Fusion Biopsy
Study NCT05273983 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioural Activation
Description: The intervention will span 6 weeks, including two intervention sessions with the primary care psychologist, and 6-weeks use of a mobile activity scheduling app (Strides). In the first intervention session, the psychologist would provide psychoeducation about depression, therapeutic rationale of behavioural activation, aid the patient in identifying their values and corresponding activities that may correspond with their values, introduce the mobile app, and help the patient schedule initial activities/goals. The second intervention session, which would be flexibly scheduled according to patient need, would focus on troubleshooting/clarification of previously discussed topics.
Study NCT04718701 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anlotinib+Toripalimab+Nab-paclitaxel
Description: Using combination treatment of anlotinib (12 mg, po. qd.) plus toripalimab (240 mg, ivgtt. q3w.) and nab-paclitaxel (260 mg/m2, ivgtt, q3w) with every 3 weeks as a cycle.
Study NCT05342844 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexmedetomidine 0.5 mcg
Description: 0.5 mcg/kg
Study NCT05342844 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexmedetomidine 1 mcg
Description: 1 mcg/kg
Study NCT04882800 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Lyric extended wear hearing aid device A
Description: Current commercially available extended wear hearing aid
Study NCT04882800 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Lyric extended wear hearing aid with fitting modification device B
Description: Extended wear hearing aid with fitting modifications
Study NCT06465056 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Botulinum toxin type A
Description: Botulinum toxin application between 3-14 days after direct eyebrow lift surgery.
Study NCT05704712 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Monetary Incentives
Description: Monetary incentives, provided in the form of pre-loaded Visa debit cards are provided to encourage exercise.
Study NCT06398340 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High Calorie Meal Intervention
Description: Subjects will receive a unhealthy meal high in calorie, sugar and fat
Study NCT06398340 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Low Calorie Meal Intervention
Description: Subjects will receive a healthy meal with balanced macronutrient, high in vegetables and dietary fibre
Study NCT05375305 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR8554 Injection
Description: SHR8554 Injection; high dose
Study NCT05375305 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR8554 Injection
Description: SHR8554 Injection; low dose
Study NCT05375305 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Saline Solution
Description: Saline Solution
Study NCT04772690 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: A resource-oriented intervention
Description: The intervention is delivered by an interdisciplinary team of occupational therapist, physiotherapist, nurse, psychologist, physician and social worker. It consists of a five-day residential stay at REHPA and a two-day follow-up stay after seven weeks at home. The residential stays include both workshops and engagement in physical and creative activities.
Study NCT05967104 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Education based on the PLISSIT model
Description: Training to the intervention group was carried out in 3 sessions of 45 minutes each week, organized by the first author (AD). In each session, training was organized based on the PLISSIT framework.
Study NCT03953144 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Synapse 3D Lung Modelling
Description: The 3D virtual models provided by Synapse 3D will be made by experts in medical image analysis using the high-resolution CT scans. Patients will have 3D virtual reconstructions of their pulmonary anatomy with the target lesion created pre-operatively.
Study NCT04964258 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TAK-105-a
Description: TAK-105-a subcutaneous solution.
Study NCT04964258 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: TAK-105-a Placebo
Description: TAK-105-a placebo-matching solution.
Study NCT04957173 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Lifestyle intervention
Description: The intervention includes a total of 17 virtual meetings and aims to achieve a weight loss of 0.8 to 1% of the initial weight per week.~This will include 3 successive phases:~1. A significant calorie restriction (A minimum deficit of 800 kcal / day of their daily energy expenditure) for a period of 4 weeks;~2. A moderate calorie restriction (minimum deficit of 500 kcal / day of their daily energy expenditure) for a period of 4 weeks;~3. A maintenance phase of weight loss for 16 weeks.~4. An optional phase of monthly follow-ups for a period of 3 months (no intervention)
Study NCT05375305 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Morphine
Description: Morphine
Study NCT05145036 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Tai-Chi
Description: Tai Chi exercise could improve muscle performance, balance and have the benefit for fall down prevention in the elders and patients with frailty.
Study NCT05145036 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Comprehensive training
Description: There are 3 exercises. Each session consisted of 10 minutes of warm-up, 40 minutes of Tai Chi, and 10 minutes of cool down.
Study NCT04611217 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dietary fiber: 10-25g
Description: 10-25 g/day of fiber
Study NCT04611217 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Dietary fiber: 5g
Description: 5 g/day of fiber
Study NCT05621473 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PICC
Description: Tunnel PICC puncture technology is a perfect combination of ultrasound-guided puncture, ECG lead technology, PICC and subcutaneous tunnel. The valve conduction PICC is equipped with an integrated ECG lead Doppler ultrasound machine. Before the catheter is placed, in the yellow area, in the ultrasound mode, evaluate the blood vessel condition, measure the blood flow velocity, and correctly select the puncture site. When the catheter is pushed close to the superior vena cava, the electrocardiograph mode is switched to complete the precise positioning of the catheter according to the principle of ECG positioning technology. A subcutaneous tunnel was prepared in the green area, and the PICC at the puncture site in the yellow area was introduced to the green area and carefully bandaged. Whole-process integrated operation, simple and efficient operation.
Study NCT06196359 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Combined Femoral and Popliteal nerve block
Description: Patients who receive a combined femoral and popliteal nerve block during surgery, fill out a questionnaire and undergo a muscle strength test before surgery, undergo functional tests, a muscle strength test and are asked about pain intensity after surgery.
Study NCT06009874 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dapagliflozin 10mg Tab
Description: patients will be treated with DAPA 10 mg once daily for three months
Study NCT06009874 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: patients will be treated with a placebo tab once daily for three months
Study NCT05726136 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: acetated Ringers
Description: After insufflation of carbon dioxide during an abdominal laparoscopic procedure, the first fluid bolus is infused. Circulatory and volume effects are studied. If cardiac output increase a second bolus is infused and studied.
Study NCT05726136 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: albumin 5%
Description: After insufflation of carbon dioxide during an abdominal laparoscopic procedure, the first bolus of fluid is infused. Circulatory and volume effects are studied. If cardiac output increases a second bolus is infused and studied.
Study NCT05726136 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: albumin 20%
Description: After insufflation of carbon dioxide during an abdominal laparoscopic procedure, the first bolus of fluid is infused. Circulatory and volume effects are studied. If cardiac output increases a second bolus is infused and studied.
Study NCT03953144 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IC-Green (ICG)
Description: ICG will be prepared as a sterile solution (2.5 mg/10mL) for injection. After vascular ligation, a 6 to 8mL bolus of ICG solution will be injected into the peripheral vein catheter, followed by a 10mL saline solution bolus. The Firefly camera will then be used for the NIF imaging. It is expected that the entire lung, except the segment which was previously isolated from blood supply, will fluoresce within 30-40 seconds, exhibiting a green hue. The surgeon will perform the pulmonary resection and the resected 'dark' lung segment will be immediately evaluated by a pathologist, depending on the pathologist findings the operation may be concluded or the patient will receive a pulmonary lobectomy.
Study NCT05551897 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Camizestrant
Description: Subjects will be administered a single oral dose of Camizestrant on Day 1 of treatment period 1 and treatment period 3.
Study NCT05551897 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Itraconazole
Description: Subjects will be administered Itraconazole twice a day on Day 1 and once daily on Day 2 and Day 3 of treatment period 2, and once daily on Day 1, 2 and 3 of treatment period 3.
Study NCT04925934 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VIB7734
Description: VIB7734